Minipuberty is a temporary, sex-specific activation of the reproductive system that occurs in infants shortly after birth.
The activation of hypothalamic-pituitary-gonadal axis in puberty is proceeded by two early periods of hormonal activity, the first during fetal life, the second during infancy (minipuberty).
It is a normal, temporary activation of the hypothalamic-pituitary-gonadal (HPG) axis that occurs in infants shortly after birth.
It is a normal physiological phase where an infant’s hormone levels—specifically testosterone in boys and estradiol (estrogen) in girls—surge to levels similar to those seen in adults.
It involves a surge in gonadotropins (LH and FSH) and sex steroids (testosterone in boys, estradiol in girls), resembling a milder version of the hormonal changes seen in adolescent puberty.
It typically begins within the first few days or weeks of life after placental hormones are cleared from the baby’s system.
In Boys: The peak usually occurs between 1 and 3 months of age and typically ends by 6 months.
In Girls: The phase is more prolonged and fluctuating, potentially lasting until 12 to 24 months, or in some cases up to 3–4 years for certain hormones like FSH.
After this period, the system remains dormant for about 10 years until the onset of “true” puberty in adolescence.
Genital Development: In boys, minipuberty is critical for penile growth, testicular descent, and the proliferation of Sertoli cells essential for future sperm production.
In girls, minipuberty supports the maturation of ovarian follicles and uterine growth.
Minipuberty influences early growth velocity and differences in body fat distribution between the sexes.
Minipuberty may play a role in early neurodevelopment, potentially influencing language organization and sex-specific characteristics.
Reproductive axis is naturally “turned on,” and this period offers a unique opportunity to diagnose congenital hormonal disorders, such as hypogonadism without needing complex stimulation tests.
While primarily a hormonal event, some physical signs may be visible:
Genital Changes: Enlargement of the testes or penis in boys; slight swelling of the labia in girls.
Breast Tissue: Both sexes may have palpable breast tissue at birth, but in girls, it may persist or grow slightly more due to the estrogen surge.
Minor Skin Changes: Infants may occasionally develop mild “baby acne” or slightly increased sweating.
Minipuberty is the second of three natural waves of HPG axis activity: the first happens in fetal life, the second is minipuberty in early infancy, and the third is true puberty in adolescence.
At birth, the sudden withdrawal of placental estrogens that suppress the HPG axis during pregnancy allows the infant’s own system to arouse and leads to pulsatile release of GnRH from the hypothalamus, stimulating the pituitary to produce LH and FSH, which then drive the gonads to produce sex hormones.
It appears to serve as a critical imprinting/priming period for reproductive development, genital maturation, brain sexual differentiation, and possibly longer-term effects on growth and body composition.
Boys: Activation starts in the first weeks. LH and testosterone rise, with testosterone peaking around 1–3 months of age, sometimes reaching levels close to those in early puberty or even adult ranges temporarily.
Levels then decline to prepubertal by about 6 months.
Girls: The process is often described as more biphasic and prolonged, lasting up to 12–24 months.
FSH levels are typically higher than in boys, and estradiol fluctuates likely due to waves of ovarian follicle maturation and regression.
Ovarian and uterine changes occur alongside these hormonal shifts.
Hormone levels during minipuberty can approach adult-like concentrations in some cases, but they remain transient and do not lead to full sexual maturation.
Most infants show no dramatic changes, but some mild, temporary signs can occur:
Boys: Slight penile and testicular growth, increased spontaneous erections, and occasionally more noticeable scrotal changes.
Minipuberty supports Sertoli cell proliferation for future sperm production, and contributes to masculinization of the brain.
Girls: Transient breast budding (gynecomastia-like), minor vaginal discharge or spotting in some cases, and ovarian follicle development.
Uterine growth can also be seen on imaging.
Both sexes: Possible neonatal acne, faster linear growth in the first months, and influences on body composition as with testosterone linked to differences in BMI or growth velocity in boys.
These signs are usually subtle and resolve on their own.
Premature or very low birth weight infants may experience more exaggerated or prolonged minipuberty.
Minipuberty provides a natural window for assessing the HPG axis without needing stimulation tests.
By measuring basal LH, FSH, and sex steroids during this period can help diagnose disorders early: Congenital hypogonadotropic hypogonadism (CHH/Kallmann syndrome):
Absent or blunted minipuberty often leads to micropenis, cryptorchidism and later issues with puberty and fertility.
Early hormone therapy in infancy is being explored in research to improve outcomes.
In conditions like Turner syndrome, minipuberty patterns may offer clues about future ovarian function and fertility potential.
It is distinct from true central precocious puberty, which involves sustained, progressive activation leading to ongoing development and requires evaluation if it occurs too early.
Using minipuberty for earlier intervention in hypogonadism and understanding its role in sex-specific developmental problems.